Consistent Use of Lipid-Lowering Therapies Decreases All-Cause Mortality Rates Among People With HIV
Study authors assessed whether lipid lowering therapies were disproportionately effective, but remain underutilized, in people living with HIV.
Cardiovascular Disease
AHA Offers Guidance for CVD Risk in Breast, Prostate Cancer
Researchers describe the CVD risks associated with hormone treatment for breast and prostate cancer and provide an evidence-based approach to detect and prevent adverse cardiovascular outcomes.
Higher Red Meat Intake Tied to Worse Imaging Measures of CV Health
Researchers used multivariable linear regression models to examine the associations between meat/fish intake and cardiovascular phenotypes of participants with cardiovascular magnetic resonance imaging data.
Post COVID-19 Inflammatory Heart Disease Among Professional Athletes
Investigators assessed prevalence of inflammatory heart disease in professional athletes with prior COVID-19 infections.
ACC Policy Statement on COVID-19 Vaccination Prioritization Based on CVD Considerations
ACC policy position statement on prioritization and allocation of COVID-19 vaccine focuses on cardiovascular disease.
Diabetes Tied to Mortality, CV Events in Chronic Coronary Syndrome
Researchers examined prevalence and prognostic impact of diabetes according to geographical regions and ethnicity in an observational registry of patients with chronic coronary syndromes.
Patients With CAP at Increased Risk for CV Events and Poor Clinical Outcomes
Investigators assessed the cumulative incidence of acute cardiovascular complications during hospitalization for community-acquired pneumonia in internal medicine units.
In Women With HIV, Hot Flashes Linked to Surrogate Markers of Cardiovascular Disease Risk
In this study, researchers explored the relationship between hot flash frequency and systemic immune activation as well as subclinical cardiac pathology among women with HIV.
Increased CVD Risk With ß-Blockers for HTN in Veterans With HIV
Researchers used propensity matching to examine the risk of incident/recurrent CVD or death, incident CVD, and incident heart failure by antihypertensive class among veterans with HIV and incident hypertension.
Marine Omega-3 Fatty Acid, Vitamin D Do Not Cut Risk for A Fib
Treatment with EPA-DHA or vitamin D3 supplement vs placebo results in no significant difference in incident atrial fibrillation over 5 years.
-
Loading...
-
Loading...
Next post in General Infectious Disease
